HRA Pharma Files FDA Application for First Over-the-Counter Oral Contraceptive
Andy Henton2022-07-11T19:39:07-04:00July 11th, 2022|Categories: Featured, Industry News|Tags: BirthControl, healthcare, HEOR, OTC, pharma|
HRA Pharma has submitted its application for the US’s first over-the-counter (OTC) birth control pill. The company, a subsidiary of [...]
FDA Pauses Cialis Prescription-to-OTC Trial
Andy Henton2022-06-01T22:12:26-04:00June 1st, 2022|Categories: Featured, Industry News|Tags: clinicaltrials, HEOR, OTC, Therapeutic|
The US Food and Drug Administration (FDA) has put a wrench in Sanofi’s efforts to transition its erection dysfunction medication [...]
Receive essential insights, resources and content direct to your inbox!
Hit subscribe to stay informed!
Advertisement
Latest News
Featured Webinars
Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters
Tuesday, December 5, 2023
Sponsor: ICON
EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025
Friday, November 10, 2023
Sponsor: OpenHealth
Cell & Gene Therapies – Beginning with the End in Mind
Thursday, November 2, 2023
Sponsor: Magnolia Market Access
Categories
Artificial Intelligence
Careers
Clinical Trials
Cost Effectiveness
Data Analytics & Syndicated Reports
Healthcare Financing
Health Databases
Health Equity
Health Policy
Health Tech Assessment
Integrated Evidence Assessment & Planning
Market Access
Medical Affairs
Patient Outcomes & Engagement
Pricing & Reimbursement
Real World Data
Real World Evidence
Value Assessment
Value Communication